Form 4 · Filed Jul 31, 2026, 09:13 PM UTC
ARTV/Artiva Biotherapeutics, Inc.
RA CAPITAL MANAGEMENT, L.P. — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 31, 2026 | P | buy | 24,944 | $10 | $247,694 | 17,329,570 |
| Jul 29, 2026 | P | buy | 20,824 | $10 | $208,032 | 17,304,626 |
Source: SEC EDGAR raw filing ↗ · Accession 0001231919-26-000817